<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.1" specific-use="sps-1.9" article-type="case-report" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ABC HF</journal-id>
<journal-title-group>
<journal-title>ABC: Heart Failure &#x26; Cardiomyopathy</journal-title>
<abbrev-journal-title abbrev-type="publisher">ABC Heart Fail Cardiomyop</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">0000-0000</issn>
<publisher>
<publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">abchf.20210004</article-id>
<article-id pub-id-type="doi">10.36660/abchf.20210004</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject></subj-group></article-categories>
<title-group>
<article-title>Heart Failure Due to Anomalous Pulmonary Vein Connection Associated with Atrial Septal Defect</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0002-1761-8662</contrib-id>
<name><surname>Bonatto</surname><given-names>Marcely Gimenes</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref> <xref ref-type="corresp" rid="c1"/></contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0002-6351-4995</contrib-id>
<name><surname>Freitas</surname><given-names>Ana Karyn Ehrenfried de</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0002-4551-1096</contrib-id>
<name><surname>Rocha</surname><given-names>Let&#xED;cia dos Santos de Oliveira</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0002-3621-193X</contrib-id>
<name><surname>Collatusso</surname><given-names>Claudinei</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0003-3144-6737</contrib-id>
<name><surname>Torres</surname><given-names>Rafael de Almeida</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0002-2936-8541</contrib-id>
<name><surname>Blume</surname><given-names>Gustavo Gavazzoni</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0002-4741-322X</contrib-id>
<name><surname>Moura</surname><given-names>L&#xED;dia Zytynski</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<aff id="aff1">
<label>1</label>
<institution content-type="orgname">Hospital Santa Casa de Curitiba</institution>
<addr-line>
<named-content content-type="city">Curitiba</named-content>
<named-content content-type="state">PR</named-content></addr-line>
<country country="BR">Brazil</country>
<institution content-type="original">Hospital Santa Casa de Curitiba, Curitiba, PR - Brazil</institution></aff>
<aff id="aff2">
<label>2</label>
<institution content-type="orgname">Hospital Pequeno Pr&#xED;ncipe</institution>
<addr-line>
<named-content content-type="city">Curitiba</named-content>
<named-content content-type="state">PR</named-content></addr-line>
<country country="BR">Brazil</country>
<institution content-type="original">Hospital Pequeno Pr&#xED;ncipe, Curitiba, PR - Brazil</institution></aff>
<aff id="aff3">
<label>3</label>
<institution content-type="orgname">Hospital Marcelino Champagnat</institution>
<addr-line>
<named-content content-type="city">Curitiba</named-content>
<named-content content-type="state">PR</named-content></addr-line>
<country country="BR">Brazil</country>
<institution content-type="original">Hospital Marcelino Champagnat, Curitiba, PR - Brazil</institution></aff>
<aff id="aff4">
<label>4</label>
<institution content-type="orgname">Pontif&#xED;cia Universidade Cat&#xF3;lica do Paran&#xE1;</institution>
<addr-line>
<named-content content-type="city">Curitiba</named-content>
<named-content content-type="state">PR</named-content></addr-line>
<country country="BR">Brazil</country>
<institution content-type="original">Pontif&#xED;cia Universidade Cat&#xF3;lica do Paran&#xE1;, Curitiba, PR - Brazil</institution></aff></contrib-group>
<author-notes>
<corresp id="c1"><bold>Mailing Address: Marcely Gimenes Bonatto</bold> &#x2022; Avenida Silva Jardim, 2939, apto 81, &#xC1;gua Verde. Postal Code <postal-code>80240-020</postal-code>, Curitiba, PR - Brazil. E-mail: <email>marcelybonatto@gmail.com</email></corresp>
<fn fn-type="conflict">
<p><bold>Potencial conflito de interesses</bold></p>
<p>No potential conflict of interest relevant to this article was reported.</p></fn>
<fn fn-type="con">
<p><bold>Author Contributions</bold></p>
<p>Conception and design of the research: Bonatto MG; Acquisition of data, Analysis and interpretation of the data and Writing of the manuscript: Bonatto MG, Freitas AKE; Critical revision of the manuscript for intellectual content: Bonatto MG, Freitas AKE, Rocha LSO, Moura LAZ; Doctor responsible for the patient: Collatusso C; Assistance in imaging methods: Torres RA, Blume GG.</p></fn></author-notes>
<pub-date publication-format="electronic" date-type="pub">
<day>06</day>
<month>07</month>
<year>2021</year></pub-date>
<pub-date publication-format="electronic" date-type="collection">
<season>Jul-Sep</season>
<year>2021</year></pub-date>
<volume>1</volume>
<issue>1</issue>
<fpage>70</fpage>
<lpage>73</lpage>
<history>
<date date-type="received">
<day>28</day>
<month>04</month>
<year>2021</year></date>
<date date-type="rev-recd">
<day>18</day>
<month>05</month>
<year>2021</year></date>
<date date-type="accepted">
<day>11</day>
<month>06</month>
<year>2021</year></date>
</history>
<permissions>
<license license-type="open-access" xml:lang="en" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p></license></permissions>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Heart Failure/physiopathologyu</kwd>
<kwd>Darinage</kwd>
<kwd>Pulmonary Veins</kwd>
<kwd>Heart Septal Defects, Atrial</kwd>
<kwd>Heart Defects,Congenital</kwd>
<kwd>Cardiomegaly</kwd>
<kwd>Echocardiography/methods</kwd></kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="12"/>
<page-count count="4"/></counts></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Anomalous pulmonary vein dreinage (APVD) is a rare disease, accounting for nearly 1 to 3% of congenital heart diseases.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref> It may be total, when all PVs are involved, or partial, when only some PVs drain anomalously into one or more systemic veins or directly into the right atrium (RA).<xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B2"><sup>2</sup></xref> This condition occurs alone or in association with an interatrial septal defect, more often sinus venosus interatrial communication (IAC) (which accounts for nearly 5% of all IAC cases).<xref ref-type="bibr" rid="B3"><sup>3</sup></xref></p>
<p>Patients with this condition may remain asymptomatic until adulthood. However, overload of right chambers may trigger symptoms, especially reduced functional capacity and progressive dyspnea, in addition to the development of pulmonary hypertension (PH) and ventricular dysfunction, which is the most severe disease scenario.<xref ref-type="bibr" rid="B3"><sup>3</sup></xref> Recognizing these symptoms and establishing early diagnosis and treatment is crucial to avoid disease progression and its prognostic implications.</p>
<p>We present a case of heart failure (HF) due to partial anomalous pulmonary vein dreinage (PAPVD) associated with IAC with reverse remodeling after surgical correction in adulthood.</p>
</sec>
<sec sec-type="cases">
<title>Clinical case</title>
<p>A previously healthy 36-year-old patient was admitted to the emergency department with dyspnea that started nearly 15 days before and progressively worsened with time, evolving to dyspnea at rest, associated lower limb (LL) edema and orthopnea. On admission, the patient presented with tachydyspnea, blood pressure of 100x60 mm Hg, heart rate of 96 bpm, respiratory rate of 26 irpm, saturation of 93% on oxygen 4 L/min via a nasal cannula. Examination revealed the presence of pathological jugular vein engorgement and hepatojugular reflux. Pulmonary auscultation showed crackles up to the bilateral middle third. Furthermore, we observed propulsive apex beat and palpable right ventricle (RV) by means of hooking palpation, with systolic murmur 3+/6+ more evident in the left paraesternal region (accessory aortic focus) irradiating to the entire precordium, as well as rhythmic heart sounds with loud B2. Abdominal assessment revealed painful and palpable liver located 4 cm below the right costal margin, presence of bowel sounds, and no peritoneal signs. Finally, the patient presented with LL edema 3+/4+.</p>
<p>Chest X-ray showed significant cardiomegaly, with increased apex beat and increased pulmonary artery trunk (PT), enlarged pulmonary hilum, and changes in vascular network, suggestive of congestion (<xref ref-type="fig" rid="f1">Figure 1</xref>A). Electrocardiogram revealed sinus rhythm with right axis deviation, right bundle branch block, signs of biventricular and right atrium (RA) overload (<xref ref-type="fig" rid="f1">Figure 1</xref>B). Laboratory tests did not show relevant changes.</p>
<fig id="f1">
<label>Figure 1</label>
<caption>
<title>Complementary tests. A: Chest X-ray. B: Electrocardiogram. C: Chest computed tomography angiography (blue arrow: entrance of the right pulmonary vein into the right atrium). D: Magnetic resonance imaging (red arrow: entrance of the pulmonary vein into the right atrium).</title></caption>
<graphic xlink:href="0000-0000-abchf-001-01-0070-gf01.tif"/></fig>
<p>Transthoracic echocardiogram showed PH (pulmonary artery systolic pressure [PASP] of 85 mmHg), major right chamber dilatation with RV dysfunction, left ventricle (LV) systolic dysfunction, grade 2 diastolic dysfunction, moderate pulmonary insufficiency, and major tricuspid insufficiency (<xref ref-type="table" rid="t1">Table 1</xref>). These findings were confirmed by transesophageal echocardiogram, which also revealed the presence of wide sinus venosus IAC, measuring 38 mm in its greatest diameter.</p>
<table-wrap id="t1">
<label>Table 1</label>
<caption>
<title>Evolution of echocardiographic and magnetic resonance findings before the procedure and 4 months and 1 year after treatment</title></caption>
<table frame="hsides" rules="rows">
<colgroup width="20%">
<col/>
<col/>
<col/>
<col/>
<col/></colgroup>
<thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
<tr>
<th valign="middle" align="left"/>
<th valign="middle" align="center">Magnetic resonance imaging</th>
<th valign="middle" align="center">Baseline echocardiogram</th>
<th valign="middle" align="center">Echocardiogram 4 months after correction</th>
<th valign="middle" align="center">Echocardiogram 1 year after correction</th></tr></thead>
<tbody style="border-bottom: thin solid; border-color: #000000">
<tr>
<td valign="middle" align="left">Right atrium</td>
<td valign="middle" align="center">Dilated</td>
<td valign="middle" align="center">143 mL/m<sup>2</sup></td>
<td valign="middle" align="center">Increased</td>
<td valign="middle" align="center">36 mL/m<sup>2</sup></td></tr>
<tr>
<td valign="middle" align="left">Left atrium</td>
<td valign="middle" align="center">27 mm</td>
<td valign="middle" align="center">39 mm</td>
<td valign="middle" align="center">39 mm</td>
<td valign="middle" align="center">39 mm</td></tr>
<tr>
<td valign="middle" align="left">Left ventricle</td>
<td valign="middle" align="center">739x591 mL</td>
<td valign="middle" align="center">46 mm</td>
<td valign="middle" align="center">42 mm</td>
<td valign="middle" align="center">44 mm</td></tr>
<tr>
<td valign="middle" align="left">RV functional assessment</td>
<td valign="middle" align="center">EF 19%</td>
<td valign="middle" align="center">FAC 25%</td>
<td valign="middle" align="center">FAC 31%</td>
<td valign="middle" align="center">FAC 24%</td></tr>
<tr>
<td valign="middle" align="left">Left ventricle</td>
<td valign="middle" align="center">178x141 mL</td>
<td valign="middle" align="center">50x44 mm</td>
<td valign="middle" align="center">50x37 mm</td>
<td valign="middle" align="center">50x36 mm</td></tr>
<tr>
<td valign="middle" align="left">LVEF</td>
<td valign="middle" align="center">20%</td>
<td valign="middle" align="center">26%</td>
<td valign="middle" align="center">51%</td>
<td valign="middle" align="center">54%</td></tr>
<tr>
<td valign="middle" align="left">Pulmonary insufficiency</td>
<td valign="middle" align="center">Unvalued</td>
<td valign="middle" align="center">Moderate</td>
<td valign="middle" align="center">Moderate</td>
<td valign="middle" align="center">Moderate</td></tr>
<tr>
<td valign="middle" align="left">Tricuspid insufficiency</td>
<td valign="middle" align="center">Unvalued</td>
<td valign="middle" align="center">Massive</td>
<td valign="middle" align="center">Moderate</td>
<td valign="middle" align="center">Mild to moderate</td></tr>
<tr>
<td valign="middle" align="left">Pulmonary trunk</td>
<td valign="middle" align="center">52 mm</td>
<td valign="middle" align="center">39 mm</td>
<td valign="middle" align="center">40 mm</td>
<td valign="middle" align="center">43 mm</td></tr>
<tr>
<td valign="middle" align="left">PASP</td>
<td valign="middle" align="center">CIA</td>
<td valign="middle" align="center">85 mmHg</td>
<td valign="middle" align="center">57 mmHg</td>
<td valign="middle" align="center">46 mmHg</td></tr>
<tr>
<td valign="middle" align="left">Other findings</td>
<td valign="middle" align="center">Possible right inferior APVC to RA</td>
<td valign="middle" align="center">IAC 38 mm</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/></tr></tbody></table>
<table-wrap-foot>
<fn id="TFN1">
<p>VD: ventr&#xED;culo direito; FEVE: fra&#xE7;&#xE3;o de eje&#xE7;&#xE3;o do ventr&#xED;culo esquerdo; PSAP: press&#xE3;o sist&#xF3;lica da art&#xE9;ria pulmonar; FE: fra&#xE7;&#xE3;o de eje&#xE7;&#xE3;o; DAVP: drenagem an&#xF4;mala da veia pulmonar; AD: &#xE1;trio direito; FAC: fra&#xE7;&#xE3;o de altera&#xE7;&#xE3;o da &#xE1;rea do ventr&#xED;culo direito; CIA: comunica&#xE7;&#xE3;o interatrial.</p></fn></table-wrap-foot></table-wrap>
<p>Chest computed tomography angiography (CTA) was requested to investigate the possible causes of PH, showing cardiomegaly involving the right chambers, negative results for pulmonary thromboembolism but with signs of pulmonary artery hypertension (dilated PA trunk measuring 5.2 cm) (<xref ref-type="fig" rid="f1">Figure 1</xref>C).</p>
<p>On cardiac magnetic resonance, significant biventricular dilation and dysfunction (LV ejection fraction [EF] of 19% and RVEF of 20%) were found, as well as dilated RA and possible right inferior APVD for RA and PT dilatation (<xref ref-type="fig" rid="f1">Figure 1</xref>D).</p>
<p>Initial clinical measures were taken to compensate the patient using intravenous diuretics and oral vasodilators. Subsequently, right heart catheterization was conducted, revealing wide sinus venosus IAC, right superior pulmonary vein with drainage in the superior vena cava, and right inferior pulmonary vein with drainage in the RA roof, RA oxymetric jump, HP (PASP 53 mmHg, pulmonary vascular resistance [PVR]: 3.04 woods), pulmonary-systemic flow ratio (Qp/Qs): 3.79/1, and PVR/systemic vascular resistance (SVR) 0,11.</p>
<p>The patient underwent surgical correction consisting of atrioseptoplasty with redirection of pulmonary vein blood flow, with good evolution. He received hospital discharge and was prescribed with enalapril 5 mg 12/12 h (maximum tolerated due to hypotension), bisoprolol 10 mg/d, spironolactone 25 mg/d, and furosemide 40 mg/d. The patient returned to the outpatient clinic 4 months after the procedure, asymptomatic, with follow-up echocardiogram showing reverse remodeling (LVEF of 51%) and moderate pulmonary and tricuspid insufficiency. These findings were maintained at late follow-up with a new echocardiogram 1 year after the procedure, with LVEF of 54%, moderate pulmonary insufficiency, and mild to moderate tricuspid insufficiency.</p>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>PAPVD usually occurs during fetal development, secondary to failure of one or more pulmonary veins of right lung upper lobe in connecting to the left atrium.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B4"><sup>4</sup></xref> Physiologically, it produce a shunt from left to right, similar to an atrial septal defect, allowing for the already oxygenated blood to circulate again to the lungs, resulting in excessive pulmonary blood flow. In 80 to 90% of the cases, drainage occurs to the right and is associated with atrial septal defects, more commonly sinus-venosus IAC.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref></p>
<p>Many adults with PAPVD are accidentally diagnosed by chest images taken for any other indication, either with CTA in an emergency service to rule out pulmonary embolism, during cardiac catheterization for coronary intervention, or as part of an assessment of post-radiofrequency catheter ablation.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref> Most patients with isolated PAPVD are asymptomatic.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref> However, when this condition is associated with IAC, left-to-right (L-R) shunt occurs, which is responsible for increased right chamber flow and pressure leading to the remodeling of these chambers and of pulmonary vasculature and culminating in symptoms and in PH.<xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref> Since many patients remain asymptomatic up to adulthood, early diagnoses eventually occur as an incidental finding in less than 1% of the cases.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref> In the remaining cases, diagnostic suspicion based symptoms directs the investigation.</p>
<p>The presence of IAC alone may not be responsible for the onset of symptoms. The magnitude and direction of flow depend on defect size and on the filling pressure of each ventricle.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref> As a rule, the septal orifice needs to measure at least 10 mm, have a Qp/Qs &#x3E; 1.5/1.0, or promote right chamber dilatation in order to be considered a hemodinamically-significant L-R shunt.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref></p>
<p>The main diagnostic test for PAPVD is transthoracic echocardiogram.<xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref> However, in cases when this condition is associated with IAC, transesophageal echocardiogram, magnetic resonance imaging, or even right heart catheterization, may be required to elucidate the diagnosis. In addition to diagnosis, invasive hemodynamic assessment allows to calculate Qp/Qs ratio, an important information for therapeutic planning.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref></p>
<p>The treatment of most PAPVD cases consists of clinical follow-up.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref> Conversely, there is an increase in morbidity and mortality rates when cases of significant IAC do not receive early treatment. Patient&#x2019;s age and pulmonary pressures at the time of correction are the main outcome predictors.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B10"><sup>10</sup></xref>In both conditions, when there are symptoms, enlarged RV, or significant increase in L-R shunt (Qp/Qs &#x3E; 1.5), surgical correction is mandatory and may be responsible not only of symptom resolution<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref> but also of reducing the likelihood of late arrhythmia, HF, and PH complications. The risk of arrhythmias increases after the age of 40 in non-operated patients, with atrial flutter, being more frequent up to the age of 60 years, and atrial fibrillation becomes predominant after this age.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref></p>
<p>The short- and long-term results after surgical repair of PAPVD are excellent, and the reported complications rates are low.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref> The association between reverse remodeling and improved clinical outcomes is well established in the literature. Therapies capable of promoting EF increase and reducing ventricle sizes are associated with lower mortality in HF.<xref ref-type="bibr" rid="B11"><sup>11</sup></xref></p>
<p>In the correction of heart diseases with L-R shunt, remodeling is expected after shunt surgical correction. The reduction in RA and ventricle volumes may occur as early as 24 hours after the procedure, but is generally more evident after 6 month and may extend to up to 18 months after the procedure. There is an expected reduction in right chambers, in tricuspid reflux, and in pulmonary pressures, as well as in improvement in LVEF, as observed in the present clinical case. However, the magnitude of remodeling is inversely proportional to patient&#x2019;s age at the time of closure, which reinforces the need for urgently starting treatment soon after symptom onset and diagnosis.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B12"><sup>12</sup></xref></p>
<p>Potential complications include stenosis or obstruction of pulmonary or systemic veins, residual IACs, or new atrial arrhythmias.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref> Although rare, PH represents a special situation and, if present in an adult patient with PAPVC, may not undergo remission after repair. Advanced cases with RVP &#x3E; 8 woods or inversion of right-to-left shunt are contraindicated for surgical treatment.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>&#x2013;</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref></p>
<p>In the present report, the patient started to present with HF symptoms in adulthood, few days before admission. An etiologic investigation found APVD and IAC with important hemodynamic repercussion showing a significant increase in right chambers and in left-to-right shunt (Qp/Qs of 3.79), in addition to PH (PASP of 85 mmHg) and bilateral dysfunction. Surgical correction and pharmacological treatment of HF promoted clinical and echocardiographic improvement in an early and sustained fashion, reinforcing the importance of investigation and treatment of patients with this condition.</p>
</sec></body>
<back>
<fn-group>
<fn fn-type="supported-by" id="fn1">
<p><bold>Sources of Funding</bold></p>
<p>There were no external funding sources for this study.</p></fn>
<fn fn-type="other" id="fn2">
<p><bold>Study Association</bold></p>
<p>This study is not associated with any thesis or dissertation work.</p></fn>
<fn fn-type="other" id="fn3">
<p><bold>Ethics approval and consent to participate</bold></p>
<p>This article does not contain any studies with human participants or animals performed by any of the authors.</p></fn></fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Paladini</surname><given-names>D</given-names></name>
<name><surname>Pistorio</surname><given-names>A</given-names></name>
<name><surname>Whu</surname><given-names>LH</given-names></name></person-group>
<article-title>Meccariello G Prenatal diagnosis of total and partial anomalous pulmonary venous connection: multicenter cohort study and meta-analysis</article-title>
<source>Ultrasound Obstet Gynecol</source>
<year>2018</year>
<volume>52</volume>
<issue>1</issue>
<fpage>24</fpage>
<lpage>34</lpage></element-citation>
<mixed-citation>1. Paladini D/ Pistorio A, Whu LH, Meccariello G Prenatal diagnosis of total and partial anomalous pulmonary venous connection: multicenter cohort study and meta-analysis. Ultrasound Obstet Gynecol. 2018; 52(1): 24-34.</mixed-citation></ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>El-Kersh</surname><given-names>K</given-names></name>
<name><surname>Homsy</surname><given-names>E</given-names></name>
<name><surname>Daniels</surname><given-names>CJ</given-names></name>
<name><surname>Smith</surname><given-names>JS</given-names></name></person-group>
<article-title>Partial anomalous pulmonary venous return: A case series with management approach</article-title>
<source>Respir Med Case Rep</source>
<year>2019</year>
<volume>27</volume>
<fpage>100833</fpage>
<lpage>100833</lpage></element-citation>
<mixed-citation>2. El-Kersh K, Homsy E, Daniels CJ, Smith JS. Partial anomalous pulmonary venous return: A case series with management approach. Respir Med Case Rep. 2019; 27:100833.</mixed-citation></ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Baumgartner</surname><given-names>H</given-names></name>
<name><surname>De Backer</surname><given-names>J</given-names></name></person-group>
<comment>2020</comment>
<article-title>ESC Guidelines for the management of adult congenital heart disease</article-title>
<source>Eur Heart J</source>
<year>2021</year>
<volume>42</volume>
<issue>6</issue>
<fpage>563</fpage>
<lpage>645</lpage></element-citation>
<mixed-citation>3. Baumgartner H, De Backer J. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 2021; 42(6):563&#x2013;645.</mixed-citation></ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Paulista</surname><given-names>MD</given-names></name>
<name><surname>Paulista</surname><given-names>ALP</given-names></name>
<etal/></person-group>
<article-title>Tratamento cir&#xFA;rgico da conex&#xE3;o an&#xF4;mala parcial das veias pulmonares em veia cava superior</article-title>
<source>Rev Bras Cir Cardiovasc</source>
<year>2009</year>
<volume>24</volume>
<issue>2</issue>
<fpage>133</fpage>
<lpage>137</lpage></element-citation>
<mixed-citation>4. Paulista MD, Paulista ALP, et al. Tratamento cir&#xFA;rgico da conex&#xE3;o an&#xF4;mala parcial das veias pulmonares em veia cava superior. Rev Bras Cir Cardiovasc. 2009; 24(2):133-7.</mixed-citation></ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>AboulHosn</surname><given-names>JA</given-names></name>
<name><surname>Criley</surname><given-names>JM</given-names></name>
<name><surname>Stringer</surname><given-names>WW</given-names></name></person-group>
<article-title>Partial anomalous pulmonary venous return: Case report and review of the literature</article-title>
<source>Cathet.Cardiovasc Interv</source>
<volume>58</volume>
<issue>4</issue>
<fpage>548</fpage>
<lpage>552</lpage></element-citation>
<mixed-citation>5. AboulHosn JA, Criley JM, Stringer WW. Partial anomalous pulmonary venous return: Case report and review of the literature. Cathet.Cardiovasc Interv.; 58(4):548&#x2013;52.</mixed-citation></ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Alsoufi</surname><given-names>S</given-names></name>
<name><surname>Cai</surname><given-names>GS</given-names></name>
<name><surname>VanArsdell</surname><given-names>WG</given-names></name>
<name><surname>Williams</surname><given-names>CA</given-names></name>
<name><surname>Caldarone</surname><given-names>JG</given-names></name></person-group>
<article-title>Coles: Outcomes after surgical treatment of children with partial anomalous pulmonary venous connection</article-title>
<source>Ann Thorac Surg</source>
<year>2007</year>
<volume>84</volume>
<fpage>2020</fpage>
<lpage>2026</lpage></element-citation>
<mixed-citation>6. Alsoufi, S. Cai, G.S. VanArsdell, W.G. Williams, C.A. Caldarone, J.G. Coles: Outcomes after surgical treatment of children with partial anomalous pulmonary venous connection. <italic>Ann Thorac Surg</italic>. 2007. 84:2020-6.</mixed-citation></ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name><surname>Gatzoulis</surname><given-names>Michael A</given-names></name>
<name><surname>Webb</surname><given-names>Gary D</given-names></name>
<name><surname>Daubeney</surname><given-names>Piers EF</given-names></name></person-group>
<source>Diagnosis and management of adult congenital heart disease</source>
<edition>Third edition</edition>
<publisher-loc>Philadelphia, PA</publisher-loc>
<publisher-name>Elsevier</publisher-name>
<year>2018</year></element-citation>
<mixed-citation>7. Gatzoulis, Michael A., Webb, Gary D., Daubeney, Piers E. F. Diagnosis and management of adult congenital heart disease. Third edition. | Philadelphia, PA. Elsevier, [2018].</mixed-citation></ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Pendela</surname><given-names>VS</given-names></name>
<name><surname>Tan</surname><given-names>BE</given-names></name>
<name><surname>Chowdhury</surname><given-names>M</given-names></name>
<name><surname>Chow</surname><given-names>M</given-names></name></person-group>
<article-title>Partial Anomalous Pulmonary Venous Return Presenting in Adults: A Case Series With Review of Literature</article-title>
<source>Cureus</source>
<year>2020</year>
<volume>12</volume>
<issue>6</issue>
<elocation-id>e8388</elocation-id></element-citation>
<mixed-citation>8. Pendela VS, Tan BE, Chowdhury M, Chow M. Partial Anomalous Pulmonary Venous Return Presenting in Adults: A Case Series With Review of Literature. Cureus. 2020;12(6):e8388.</mixed-citation></ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Bhatt</surname><given-names>AB</given-names></name></person-group>
<article-title>Congenital Heart Disease in the Older Adult. MAS on behalf of the American Heart Association Council on Clinical Cardiology</article-title>
<source>Circulation</source>
<year>2015</year>
<volume>131</volume>
<issue>21</issue>
<fpage>1884</fpage>
<lpage>1931</lpage></element-citation>
<mixed-citation>9. Bhatt AB.. Congenital Heart Disease in the Older Adult. MAS on behalf of the American Heart Association Council on Clinical Cardiology. Circulation. 2015;131(21):1884&#x2013;931</mixed-citation></ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Le Gloan</surname><given-names>L</given-names></name>
<name><surname>Legendre</surname><given-names>A</given-names></name>
<name><surname>Iserin</surname><given-names>L</given-names></name>
<name><surname>Ladouceur</surname><given-names>M</given-names></name></person-group>
<article-title>Pathophysiology and natural history of atrial septal defect</article-title>
<source>J Thorac Dis</source>
<year>2018</year>
<volume>10</volume>
<supplement>Suppl 24</supplement>
<fpage>S2854</fpage>
<lpage>S2863</lpage>
<pub-id pub-id-type="doi">10.21037/jtd.2018.02.80</pub-id></element-citation>
<mixed-citation>10. Le Gloan L, Legendre A, Iserin L, Ladouceur M. Pathophysiology and natural history of atrial septal defect. <italic>J Thorac Dis</italic>. 2018;10(Suppl 24):S2854-S2863. doi:10.21037/jtd.2018.02.80</mixed-citation></ref>
<ref id="B11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kramer</surname><given-names>DG</given-names></name>
<name><surname>Trikalinos</surname><given-names>TA</given-names></name>
<name><surname>Kent</surname><given-names>AJV</given-names></name>
<name><surname>Konstam</surname><given-names>MA</given-names></name>
<name><surname>Udelson</surname><given-names>JE</given-names></name></person-group>
<article-title>Quantitative Evaluation of Drug or Device Effects on Ventricular Remodeling as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection Fraction: a Meta-analytic Approach</article-title>
<source>J Am Coll Cardiol</source>
<year>2010</year>
<month>07</month>
<day>27</day>
<volume>56</volume>
<issue>5</issue>
<fpage>392</fpage>
<lpage>406</lpage></element-citation>
<mixed-citation>11. Kramer DG,Trikalinos TA, Kent AJV, Konstam MA, Udelson, JE. Quantitative Evaluation of Drug or Device Effects on Ventricular Remodeling as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection Fraction: a Meta-analytic Approach. J Am Coll Cardiol. 2010 July 27; 56(5): 392&#x2013;406.</mixed-citation></ref>
<ref id="B12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kumar</surname><given-names>P</given-names></name>
<name><surname>Sarkar</surname><given-names>A</given-names></name>
<name><surname>Kar</surname><given-names>SK</given-names></name></person-group>
<article-title>Assessment of ventricular function in patients of atrial septal defect by strain imaging before and after correction</article-title>
<source>Ann Card Anaesth</source>
<year>2019</year>
<volume>22</volume>
<issue>1</issue>
<fpage>41</fpage>
<lpage>46</lpage></element-citation>
<mixed-citation>12. Kumar P, Sarkar A, Kar SK. Assessment of ventricular function in patients of atrial septal defect by strain imaging before and after correction. <italic>Ann Card Anaesth</italic>. 2019;22(1):41-6.</mixed-citation></ref></ref-list>
</back>
<sub-article article-type="translation" id="S01" xml:lang="pt">
<front-stub>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Relato de Caso</subject></subj-group></article-categories>
<title-group>
<article-title>Insufici&#xEA;ncia Card&#xED;aca por Drenagem An&#xF4;mala de Veias Pulmonares Associada a Comunica&#xE7;&#xE3;o Interatrial</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0002-1761-8662</contrib-id>
<name><surname>Bonatto</surname><given-names>Marcely Gimenes</given-names></name><xref ref-type="aff" rid="aff5"><sup>1</sup></xref> <xref ref-type="corresp" rid="c2"/></contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0002-6351-4995</contrib-id>
<name><surname>Freitas</surname><given-names>Ana Karyn Ehrenfried de</given-names></name><xref ref-type="aff" rid="aff5"><sup>1</sup></xref></contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0002-4551-1096</contrib-id>
<name><surname>Rocha</surname><given-names>Let&#xED;cia dos Santos de Oliveira</given-names></name><xref ref-type="aff" rid="aff6"><sup>2</sup></xref></contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0002-3621-193X</contrib-id>
<name><surname>Collatusso</surname><given-names>Claudinei</given-names></name><xref ref-type="aff" rid="aff5"><sup>1</sup></xref></contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0003-3144-6737</contrib-id>
<name><surname>Torres</surname><given-names>Rafael de Almeida</given-names></name><xref ref-type="aff" rid="aff7"><sup>3</sup></xref></contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0002-2936-8541</contrib-id>
<name><surname>Blume</surname><given-names>Gustavo Gavazzoni</given-names></name><xref ref-type="aff" rid="aff8"><sup>4</sup></xref></contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0002-4741-322X</contrib-id>
<name><surname>Moura</surname><given-names>L&#xED;dia Zytynski</given-names></name><xref ref-type="aff" rid="aff8"><sup>4</sup></xref></contrib>
<aff id="aff5">
<label>1</label>
<addr-line>
<named-content content-type="city">Curitiba</named-content>
<named-content content-type="state">PR</named-content></addr-line>
<country country="BR">Brasil</country>
<institution content-type="original">Hospital Santa Casa de Curitiba, Curitiba, PR - Brasil</institution></aff>
<aff id="aff6">
<label>2</label>
<addr-line>
<named-content content-type="city">Curitiba</named-content>
<named-content content-type="state">PR</named-content></addr-line>
<country country="BR">Brasil</country>
<institution content-type="original">Hospital Pequeno Pr&#xED;ncipe, Curitiba, PR - Brasil</institution></aff>
<aff id="aff7">
<label>3</label>
<addr-line>
<named-content content-type="city">Curitiba</named-content>
<named-content content-type="state">PR</named-content></addr-line>
<country country="BR">Brasil</country>
<institution content-type="original">Hospital Marcelino Champagnat, Curitiba, PR - Brasil</institution></aff>
<aff id="aff8">
<label>4</label>
<addr-line>
<named-content content-type="city">Curitiba</named-content>
<named-content content-type="state">PR</named-content></addr-line>
<country country="BR">Brasil</country>
<institution content-type="original">Pontif&#xED;cia Universidade Cat&#xF3;lica do Paran&#xE1;, Curitiba, PR - Brasil</institution></aff></contrib-group>
<author-notes>
<corresp id="c2"><bold>Correspond&#xEA;ncia: Marcely Gimenes Bonatto</bold> &#x2022; Avenida Silva Jardim, 2939, apto 81, &#xC1;gua Verde. CEP <postal-code>80240-020</postal-code>, Curitiba, PR - Brasil. E-mail: <email>marcelybonatto@gmail.com</email></corresp>
<fn fn-type="conflict">
<p><bold>Potencial conflito de interesses</bold></p>
<p>N&#xE3;o h&#xE1; conflito com o presente artigo</p></fn>
<fn fn-type="con">
<p><bold>Contribui&#xE7;&#xE3;o dos autores</bold></p>
<p>Concep&#xE7;&#xE3;o e desenho da pesquisa: Bonatto MG; Obten&#xE7;&#xE3;o de dados, An&#xE1;lise e interpreta&#xE7;&#xE3;o dos dados e Reda&#xE7;&#xE3;o do manuscrito: Bonatto MG, Freitas AKE; Revis&#xE3;o cr&#xED;tica do manuscrito quanto ao conte&#xFA;do intelectual importante: Bonatto MG, Freitas AKE, Rocha LSO, Moura LAZ; Cirurgi&#xE3;o respons&#xE1;vel pelo paciente: Collatusso C; Aux&#xED;lio nos m&#xE9;todos de imagem: Torres RA, Blume GG.</p></fn></author-notes>
<kwd-group xml:lang="pt">
<title>Palavras-chave</title>
<kwd>Insufici&#xEA;ncia Card&#xED;aca/fisiopatologia</kwd>
<kwd>Drenagem</kwd>
<kwd>Veias Pulmonares</kwd>
<kwd>Comunica&#xE7;&#xE3;o Interatrial</kwd>
<kwd>Cardiopatias Cong&#xEA;nitas</kwd>
<kwd>Cardiomegalia</kwd>
<kwd>Ecocardiografia/m&#xE9;todos</kwd></kwd-group></front-stub>
<body>
<sec sec-type="intro">
<title>Introdu&#xE7;&#xE3;o</title>
<p>A drenagem an&#xF4;mala de veias pulmonares (DAVP) &#xE9; uma doen&#xE7;a rara, correspondendo a cerca de 1 a 3% das cardiopatias cong&#xEA;nitas.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref> Pode existir na forma total, em que todas as veias pulmonares (VP) est&#xE3;o envolvidas, ou parcial, na qual somente algumas VP drenam de modo an&#xF4;malo para uma ou mais veias sist&#xEA;micas ou diretamente para o &#xE1;trio direito (AD).<xref ref-type="bibr" rid="B1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B2"><sup>2</sup></xref> Essa condi&#xE7;&#xE3;o ocorre isoladamente ou em associa&#xE7;&#xE3;o a um defeito do septo interatrial, mais frequentemente a comunica&#xE7;&#xE3;o interatrial (CIA) do tipo seio venoso (respons&#xE1;vel por cerca de 5% de todos os casos de CIA).<xref ref-type="bibr" rid="B3"><sup>3</sup></xref></p>
<p>Pacientes com essa condi&#xE7;&#xE3;o podem permanecer assintom&#xE1;ticos at&#xE9; a fase adulta. Entretanto, &#xE0; medida que h&#xE1; sobrecarga das c&#xE2;maras direitas, podem ocorrer sintomas, especialmente diminui&#xE7;&#xE3;o da capacidade funcional e dispneia progressiva, al&#xE9;m do desenvolvimento de hipertens&#xE3;o pulmonar (HP) e disfun&#xE7;&#xE3;o ventricular, sendo esse o cen&#xE1;rio mais grave da doen&#xE7;a.<xref ref-type="bibr" rid="B3"><sup>3</sup></xref> Reconhecer esses sintomas e estabelecer o diagn&#xF3;stico e tratamento de modo precoce &#xE9; fundamental para evitar a progress&#xE3;o da doen&#xE7;a e suas implica&#xE7;&#xF5;es progn&#xF3;sticas.</p>
<p>Apresentamos um caso de insufici&#xEA;ncia card&#xED;aca (IC) por drenagem an&#xF4;mala parcial de veias pulmonares (DAPVP) associada a CIA com remodelamento reverso ap&#xF3;s corre&#xE7;&#xE3;o cir&#xFA;rgica em idade adulta.</p>
</sec>
<sec sec-type="cases">
<title>Caso cl&#xED;nico</title>
<p>O paciente era um homem de 36 anos, previamente h&#xED;gido, encaminhado ao pronto atendimento por quadro de dispneia com in&#xED;cio h&#xE1; cerca de 15 dias com piora progressiva, evoluindo para dispneia ao repouso, associada a edema de membros inferiores (MMII) e ortopneia. Na admiss&#xE3;o, apresentava-se taquidispneico, com press&#xE3;o arterial 100x60 mmHg, frequ&#xEA;ncia card&#xED;aca 96 bpm, frequ&#xEA;ncia respirat&#xF3;ria 26 irpm, satura&#xE7;&#xE3;o 93% com cateter de oxig&#xEA;nio 4 L/min. Ao exame, constatou-se presen&#xE7;a de ingurgitamento jugular patol&#xF3;gico e refluxo hepatojugular. Na ausculta pulmonar, crepitantes at&#xE9; ter&#xE7;o m&#xE9;dio bilateral. Al&#xE9;m disso, foram observados ictus propulsivo e ventr&#xED;culo direito (VD) palp&#xE1;vel na manobra de m&#xE3;o em garra com sopro sist&#xF3;lico 3+/6+ mais evidente em regi&#xE3;o paraesternal esquerda (foco a&#xF3;rtico acess&#xF3;rio) com irradia&#xE7;&#xE3;o para todo prec&#xF3;rdio, bulhas r&#xED;tmicas com hiperfonese de B2. Abdome com f&#xED;gado doloroso e palp&#xE1;vel 4 cm abaixo do rebordo costal direito, ru&#xED;dos hidroa&#xE9;reos presentes e sem sinais peritoneais. Por fim, foi constatado edema de MMII 3+/4+.</p>
<p>A radiografia de t&#xF3;rax demonstrou cardiomegalia importante, com eleva&#xE7;&#xE3;o do ictus e aumento do tronco da art&#xE9;ria pulmonar (TP), aumento do hilo pulmonar e altera&#xE7;&#xE3;o da trama vascular, sugestivo de congest&#xE3;o (<xref ref-type="fig" rid="f2">Figura 1</xref>A). O eletrocardiograma apresentava-se com ritmo sinusal, com eixo desviado para direita, bloqueio de ramo direito, sinais de sobrecarga biventricular e de &#xE1;trio direito (AD) (<xref ref-type="fig" rid="f2">Figura 1</xref>B). Os exames laboratoriais n&#xE3;o apresentaram altera&#xE7;&#xF5;es relevantes.</p>
<fig id="f2">
<label>Figura 1</label>
<caption>
<title>Exames complementares. A: Radiografia de t&#xF3;rax. B: Eletrocardiograma. C: Angiotomografia de t&#xF3;rax (seta azul: entrada da veia pulmonar direita no &#xE1;trio direito). D: Resson&#xE2;ncia magn&#xE9;tica (seta vermelha: entrada da veia pulmonar no &#xE1;trio direito).</title></caption>
<graphic xlink:href="0000-0000-abchf-001-01-0070-gf01-pt.tif"/></fig>
<p>Foi realizado ecocardiograma transtor&#xE1;cico que demonstrou HP (press&#xE3;o sist&#xF3;lica da art&#xE9;ria pulmonar [PSAP] de 85 mmHg), dilata&#xE7;&#xE3;o importante das c&#xE2;maras direitas com disfun&#xE7;&#xE3;o de VD, disfun&#xE7;&#xE3;o sist&#xF3;lica de ventr&#xED;culo esquerdo (VE) e diast&#xF3;lica grau 2, insufici&#xEA;ncia pulmonar moderada e tric&#xFA;spide importante (<xref ref-type="table" rid="t2">Tabela 1</xref>). Esses achados foram confirmados pelo ecocardiograma transesof&#xE1;gico, que apresentou ainda presen&#xE7;a de ampla CIA do tipo seio venoso, medindo 38 mm no seu maior di&#xE2;metro.</p>
<table-wrap id="t2">
<label>Tabela 1</label>
<caption>
<title>Evolu&#xE7;&#xE3;o do ecocardiograma e por resson&#xE2;ncia magn&#xE9;tica antes do procedimento e ap&#xF3;s 4 meses e 1 ano do tratamento</title></caption>
<table frame="hsides" rules="rows">
<colgroup width="20%">
<col/>
<col/>
<col/>
<col/>
<col/></colgroup>
<thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
<tr>
<th valign="middle" align="left"/>
<th valign="middle" align="center">Resson&#xE2;ncia magn&#xE9;tica</th>
<th valign="middle" align="center">Ecocardiograma inicial</th>
<th valign="middle" align="center">Ecocardiograma 4 meses ap&#xF3;s corre&#xE7;&#xE3;o</th>
<th valign="middle" align="center">Ecocardiograma 1 ano ap&#xF3;s corre&#xE7;&#xE3;o</th></tr></thead>
<tbody style="border-bottom: thin solid; border-color: #000000">
<tr>
<td valign="middle" align="left">&#xC1;trio direito</td>
<td valign="middle" align="center">Dilatado</td>
<td valign="middle" align="center">143 mL/m<sup>2</sup></td>
<td valign="middle" align="center">Aumentado</td>
<td valign="middle" align="center">36 mL/m<sup>2</sup></td></tr>
<tr>
<td valign="middle" align="left">&#xC1;trio esquerdo</td>
<td valign="middle" align="center">27 mm</td>
<td valign="middle" align="center">39 mm</td>
<td valign="middle" align="center">39 mm</td>
<td valign="middle" align="center">39 mm</td></tr>
<tr>
<td valign="middle" align="left">Ventr&#xED;culo direito</td>
<td valign="middle" align="center">739 x 591 mL</td>
<td valign="middle" align="center">46 mm</td>
<td valign="middle" align="center">42 mm</td>
<td valign="middle" align="center">44 mm</td></tr>
<tr>
<td valign="middle" align="left">Avalia&#xE7;&#xE3;o funcional VD</td>
<td valign="middle" align="center">FE 19%</td>
<td valign="middle" align="center">FAC 25%</td>
<td valign="middle" align="center">FAC 31%</td>
<td valign="middle" align="center">FAC 24%</td></tr>
<tr>
<td valign="middle" align="left">Ventr&#xED;culo esquerdo</td>
<td valign="middle" align="center">178x141 mL</td>
<td valign="middle" align="center">50x44 mm</td>
<td valign="middle" align="center">50x37 mm</td>
<td valign="middle" align="center">50x36 mm</td></tr>
<tr>
<td valign="middle" align="left">FEVE</td>
<td valign="middle" align="center">20%</td>
<td valign="middle" align="center">26%</td>
<td valign="middle" align="center">51%</td>
<td valign="middle" align="center">54%</td></tr>
<tr>
<td valign="middle" align="left">Insufici&#xEA;ncia pulmonar</td>
<td valign="middle" align="center">N&#xE3;o avaliado</td>
<td valign="middle" align="center">Moderada</td>
<td valign="middle" align="center">Moderada</td>
<td valign="middle" align="center">Moderada</td></tr>
<tr>
<td valign="middle" align="left">Insufici&#xEA;ncia tric&#xFA;spide</td>
<td valign="middle" align="center">N&#xE3;o avaliado</td>
<td valign="middle" align="center">Maci&#xE7;a</td>
<td valign="middle" align="center">Moderada</td>
<td valign="middle" align="center">Discreta a moderada</td></tr>
<tr>
<td valign="middle" align="left">Tronco pulmonar</td>
<td valign="middle" align="center">52mm</td>
<td valign="middle" align="center">39mm</td>
<td valign="middle" align="center">40mm</td>
<td valign="middle" align="center">43mm</td></tr>
<tr>
<td valign="middle" align="left">PSAP</td>
<td valign="middle" align="center">CIA</td>
<td valign="middle" align="center">85 mmHg</td>
<td valign="middle" align="center">57 mmHg</td>
<td valign="middle" align="center">46 mmHg</td></tr>
<tr>
<td valign="middle" align="left">Outros achados</td>
<td valign="middle" align="center">Poss&#xED;vel DAVP inferior direita para AD</td>
<td valign="middle" align="center">CIA 38 mm</td>
<td valign="middle" align="center"/>
<td valign="middle" align="center"/></tr></tbody></table>
<table-wrap-foot>
<fn id="TFN2">
<p>VD: ventr&#xED;culo direito; FEVE: fra&#xE7;&#xE3;o de eje&#xE7;&#xE3;o do ventr&#xED;culo esquerdo; PSAP: press&#xE3;o sist&#xF3;lica da art&#xE9;ria pulmonar; FE: fra&#xE7;&#xE3;o de eje&#xE7;&#xE3;o; DAVP: drenagem an&#xF4;mala da veia pulmonar; AD: &#xE1;trio direito; FAC: fra&#xE7;&#xE3;o de altera&#xE7;&#xE3;o da &#xE1;rea do ventr&#xED;culo direito; CIA: comunica&#xE7;&#xE3;o interatrial.</p></fn></table-wrap-foot></table-wrap>
<p>Foi solicitada angiotomografia de t&#xF3;rax para investiga&#xE7;&#xE3;o de poss&#xED;veis causas de HP, e o resultado demostrou cardiomegalia &#xE0;s custas de c&#xE2;maras diretas, negativa para tromboembolismo pulmonar, por&#xE9;m com sinais de hipertens&#xE3;o arterial pulmonar (dilata&#xE7;&#xE3;o do tronco da AP medindo 5,2 cm) (<xref ref-type="fig" rid="f2">Figura 1</xref>C).</p>
<p>&#xC0; resson&#xE2;ncia card&#xED;aca, observou-se dilata&#xE7;&#xE3;o e disfun&#xE7;&#xE3;o sist&#xF3;lica importante biventricular (fra&#xE7;&#xE3;o de eje&#xE7;&#xE3;o [FE] do VE de 19% e do VD, de 20%), dilata&#xE7;&#xE3;o de AD, poss&#xED;vel DAVP inferior direita para AD e dilata&#xE7;&#xE3;o do TP (<xref ref-type="fig" rid="f2">Figura 1</xref>D).</p>
<p>Optou-se por medidas cl&#xED;nicas iniciais para compensa&#xE7;&#xE3;o do paciente com diur&#xE9;ticos endovenosos e vasodilatadores orais. Em seguida, foi realizado cateterismo direito, que mostrou CIA ampla do tipo seio venoso, veia pulmonar superior direita com drenagem na veia cava superior e veia pulmonar inferior direita com drenagem no teto do AD, salto oxim&#xE9;trico no AD, HP (PSAP 53 mmHg, RVP: 3,04 woods), Qp/Qs: 3,79/1 e rela&#xE7;&#xE3;o de resist&#xEA;ncia vascular pulmonar (RVP) e resist&#xEA;ncia vascular sist&#xEA;mica (RVS) (RVP/RVS) de 0,11.</p>
<p>O paciente foi submetido &#xE0; corre&#xE7;&#xE3;o cir&#xFA;rgica, sendo realizada uma atrioseptoplastia com redirecionamento do fluxo das veias pulmonares, com boa evolu&#xE7;&#xE3;o. Foi dada alta hospitalar com enalapril 5 mg 12/12 h (m&#xE1;ximo tolerado devido &#xE0; hipotens&#xE3;o), bisoprolol 10 mg/d, espironolactona 25 mg/d e furosemida 40 mg/d. O paciente retornou ao ambulat&#xF3;rio ap&#xF3;s 4 meses do procedimento, assintom&#xE1;tico, com ecocardiograma de controle demonstrando remodelamento reverso (FEVE de 51%), insufici&#xEA;ncia pulmonar e tric&#xFA;spide moderadas. Esses achados foram mantidos no seguimento tardio em novo ecocardiograma, 1 ano ap&#xF3;s o procedimento, com FEVE de 54%, insufici&#xEA;ncia pulmonar moderada e tric&#xFA;spide discreta a moderada.</p>
</sec>
<sec sec-type="discussion">
<title>Discuss&#xE3;o</title>
<p>A DAPVP normalmente ocorre durante o desenvolvimento fetal, secund&#xE1;ria &#xE0; falha de uma ou mais veias pulmonares do lobo superior do pulm&#xE3;o direito ao se conectar ao &#xE1;trio esquerdo.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B4"><sup>4</sup></xref> Fisiologicamente, ela produz um <italic>shunt</italic> da esquerda para a direita, semelhante a um defeito do septo atrial, permitindo que o sangue j&#xE1; oxigenado circule novamente para os pulm&#xF5;es, resultando em fluxo sangu&#xED;neo pulmonar excessivo. Em 80 a 90% dos casos, a drenagem ocorre &#xE0; direita e est&#xE1; associada a defeitos do septo interatrial, mais comumente a CIA do tipo seio venoso.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref></p>
<p>Muitos adultos com DAPVP ser&#xE3;o diagnosticados acidentalmente por imagens tor&#xE1;cicas realizadas para alguma outra indica&#xE7;&#xE3;o, seja com uma angiografia por tomografia computadorizada (CTA) em um servi&#xE7;o de emerg&#xEA;ncia para descartar uma embolia pulmonar, durante um cateterismo card&#xED;aco para interven&#xE7;&#xE3;o coron&#xE1;ria ou como parte de uma avalia&#xE7;&#xE3;o de abla&#xE7;&#xE3;o por cateter p&#xF3;s-radiofrequ&#xEA;ncia.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref> A grande maioria dos pacientes com DAPVP isolada &#xE9; assintom&#xE1;tica.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref> Entretanto, quando associada a CIA, ocorre um <italic>shunt</italic> esquerda-direita respons&#xE1;vel pelo aumento do fluxo e das press&#xF5;es em c&#xE2;maras direitas, o que ocasiona remodelamento dessas e da vasculatura pulmonar, culminando em sintomas e em hipertens&#xE3;o pulmonar.<xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref> Uma vez que muitos pacientes permanecem assintom&#xE1;ticos at&#xE9; a fase adulta, diagn&#xF3;sticos precoces acabam ocorrendo como achados de exames em menos de 1% dos casos.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref> Nos demais casos, a suspei&#xE7;&#xE3;o diagn&#xF3;stica baseada em sintomas direciona a investiga&#xE7;&#xE3;o.</p>
<p>A presen&#xE7;a da CIA isoladamente pode n&#xE3;o ser respons&#xE1;vel pelo aparecimento de sintomas. A magnitude e a dire&#xE7;&#xE3;o do fluxo dependem do tamanho do defeito e das press&#xF5;es de enchimento de cada um dos ventr&#xED;culos.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref> Via de regra, o orif&#xED;cio septal precisa ter um tamanho m&#xED;nimo de 10 mm, apresentar Qp/Qs &#x3E; 1,5/1,0 ou promover dilata&#xE7;&#xE3;o de c&#xE2;maras direitas para ser considerado um <italic>shunt</italic> esquerda-direita hemodinamicamente significativo.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref></p>
<p>O principal exame diagn&#xF3;stico para DAPVP &#xE9; o ecocardiograma transtor&#xE1;cico.<xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B5"><sup>5</sup></xref> Por&#xE9;m, nos casos em que h&#xE1; associa&#xE7;&#xE3;o com CIA, o ecocardiograma transesof&#xE1;gico, a resson&#xE2;ncia magn&#xE9;tica ou mesmo o cateterismo direito podem ser necess&#xE1;rios para elucidar o diagn&#xF3;stico. Al&#xE9;m do diagn&#xF3;stico, a avalia&#xE7;&#xE3;o hemodin&#xE2;mica invasiva permite calcular o &#xED;ndice de fluxo pulmonar-sist&#xEA;mico (Qp/Qs), dado importante na programa&#xE7;&#xE3;o terap&#xEA;utica.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref></p>
<p>Na DAPVP, o tratamento da maioria dos casos consiste em manter um acompanhamento cl&#xED;nico.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref> J&#xE1; nos casos de CIA significativa, h&#xE1; aumento da morbimortalidade quando n&#xE3;o tratados precocemente. A idade do paciente e as press&#xF5;es pulmonares no momento da corre&#xE7;&#xE3;o s&#xE3;o os maiores preditores de resultado.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B10"><sup>10</sup></xref> Nas duas condi&#xE7;&#xF5;es quando h&#xE1; sintomas, aumento do VD ou aumento significativo do <italic>shunt</italic> esquerda-direita (Qp/Qs &#x3E; 1,5), a corre&#xE7;&#xE3;o cir&#xFA;rgica &#xE9; mandat&#xF3;ria e pode ser respons&#xE1;vel n&#xE3;o s&#xF3; pela resolu&#xE7;&#xE3;o dos sintomas<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref> como por reduzir a possibilidade de arritmia tardia, insufici&#xEA;ncia card&#xED;aca ou complica&#xE7;&#xF5;es de hipertens&#xE3;o pulmonar. O risco de arritmias aumenta ap&#xF3;s os 40 anos em pacientes n&#xE3;o operados, com <italic>flutter</italic> atrial ocorrendo mais frequentemente at&#xE9; os 60 anos e fibrila&#xE7;&#xE3;o atrial se tornando predominante depois disso.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref></p>
<p>Os resultados de curto e longo prazo ap&#xF3;s o reparo cir&#xFA;rgico de DAPVP s&#xE3;o excelentes, e as taxas de complica&#xE7;&#xF5;es relatadas s&#xE3;o baixas.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref> A associa&#xE7;&#xE3;o entre remodelamento reverso e melhora de desfechos cl&#xED;nicos &#xE9; bem estabelecida na literatura. Terapias capazes de promover aumento de fra&#xE7;&#xE3;o de eje&#xE7;&#xE3;o e redu&#xE7;&#xE3;o das dimens&#xF5;es ventriculares est&#xE3;o associadas a menor mortalidade na IC.<xref ref-type="bibr" rid="B11"><sup>11</sup></xref></p>
<p>Na corre&#xE7;&#xE3;o de cardiopatias com <italic>shunt</italic> E-D, &#xE9; esperado que haja remodelamento ap&#xF3;s a corre&#xE7;&#xE3;o cir&#xFA;rgica do <italic>shunt</italic>. A redu&#xE7;&#xE3;o dos volumes do &#xE1;trio direito e dos ventr&#xED;culos pode ocorrer de modo precoce j&#xE1; a partir das primeiras 24 horas ap&#xF3;s o procedimento, mas de modo geral est&#xE1; mais evidente ap&#xF3;s 6 meses, podendo se estender at&#xE9; 18 meses ap&#xF3;s o procedimento. S&#xE3;o esperados redu&#xE7;&#xE3;o de c&#xE2;maras direitas, refluxo tric&#xFA;spide, press&#xF5;es pulmonares e melhora de fra&#xE7;&#xE3;o de eje&#xE7;&#xE3;o do ventr&#xED;culo esquerdo, como observado neste caso cl&#xED;nico. No entanto, a magnitude do remodelamento &#xE9; inversamente proporcional &#xE0; idade do paciente na ocasi&#xE3;o do fechamento, o que refor&#xE7;a a urg&#xEA;ncia do tratamento t&#xE3;o logo apare&#xE7;am os sintomas e seja feito o diagn&#xF3;stico.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B12"><sup>12</sup></xref></p>
<p>As complica&#xE7;&#xF5;es potenciais incluem estenose ou obstru&#xE7;&#xE3;o das veias pulmonares ou sist&#xEA;micas, CIAs residuais ou novas arritmias atriais.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B7"><sup>7</sup></xref> Embora rara, a HP representa uma situa&#xE7;&#xE3;o especial e, se presente em um paciente adulto com DAPVP, pode n&#xE3;o remitir ap&#xF3;s o reparo. Casos avan&#xE7;ados com RVP &#x3E; 8 woods ou invers&#xE3;o do <italic>shunt</italic> direita-esquerda s&#xE3;o contraindicados para o tratamento cir&#xFA;rgico.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref><sup>&#x2013;</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref></p>
<p>Neste relato, o paciente come&#xE7;ou a apresentar sintomas de IC j&#xE1; na idade adulta, poucos dias antes da admiss&#xE3;o. Na investiga&#xE7;&#xE3;o etiol&#xF3;gica, encontrou-se DAVP e a CIA com importante repercuss&#xE3;o hemodin&#xE2;mica demonstrando aumento expressivo das c&#xE2;maras direitas e do <italic>shunt</italic> esquerda-direita (Qp/Qs de 3,79), al&#xE9;m de HP (PSAP de 85 mmHg) e disfun&#xE7;&#xE3;o biventricular. A corre&#xE7;&#xE3;o cir&#xFA;rgica e o tratamento farmacol&#xF3;gico da IC promoveram melhora cl&#xED;nica e ecocardiogr&#xE1;fica de modo precoce e sustentado, ressaltando a import&#xE2;ncia da investiga&#xE7;&#xE3;o e tratamento dos pacientes com essa condi&#xE7;&#xE3;o.</p>
</sec></body>
<back>
<fn-group>
<fn fn-type="supported-by" id="fn4">
<p><bold>Fontes de financiamento</bold></p>
<p>O presente estudo n&#xE3;o teve fontes de financiamento externas.</p></fn>
<fn fn-type="other" id="fn5">
<p><bold>Vincula&#xE7;&#xE3;o acad&#xEA;mica</bold></p>
<p>N&#xE3;o h&#xE1; vincula&#xE7;&#xE3;o deste estudo a programas de p&#xF3;s-gradua&#xE7;&#xE3;o.</p></fn>
<fn fn-type="other" id="fn6">
<p><bold>Aprova&#xE7;&#xE3;o &#xE9;tica e consentimento informado</bold></p>
<p>Este artigo n&#xE3;o cont&#xE9;m estudos com humanos ou animais realizados por nenhum dos autores.</p></fn></fn-group>
</back></sub-article>
</article>